InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by STOKELY DAN, Chief Financial Officer. Officer active across 1 companies, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 10 reports have been logged. The latest transaction was filed on 1 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
€11,53322,914 shares@ €0.50335.55% mcap16.1% of flow
Common Stock
SEC:0001415889-22-000260·
€11,53322,914 shares@ €0.50335.55% mcap8.0% of flow
Common Stock
SEC:0001415889-22-000260:0·
€39,76528,127 shares@ €1.413819.13% mcap55.4% of flow
Common Stock
SEC:0001415889-21-005020·
€39,76528,127 shares@ €1.413819.13% mcap27.7% of flow
Common Stock
SEC:0001415889-21-005020:0·
0335,000 shares0
Common Stock
SEC:0001415889-21-004869·
0335,000 shares0
Common Stock
SEC:0001415889-21-004869:0·
€8,11022,500 shares@ €0.36043.90% mcap11.3% of flow
Common Stock
SEC:0001415889-21-003253·
€8,11022,500 shares@ €0.36043.90% mcap5.6% of flow
Common Stock
SEC:0001415889-21-003253:0·
€12,38035,000 shares@ €0.35375.96% mcap17.2% of flow
Common Stock
SEC:0001415889-21-002569·
€12,38035,000 shares@ €0.35375.96% mcap8.6% of flow
Common Stock
SEC:0001415889-21-002569:0·
10 of 10 declarations
About STOKELY DAN
Dan Stokely is the CFO of Ampio Pharmaceuticals, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Dan ensures that Ampio maintains high standards of financial integrity and transparency. His experience in finance is crucial to support Ampio's growth strategy.
